Redmile Group as of March 31, 2020
Portfolio Holdings for Redmile Group
Redmile Group holds 69 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 7.0 | $249M | 11M | 22.21 | |
| Amicus Therapeutics (FOLD) | 6.5 | $233M | 25M | 9.24 | |
| Deciphera Pharmaceuticals | 5.9 | $211M | 5.1M | 41.17 | |
| Biogen Idec (BIIB) | 5.2 | $186M | 589k | 316.38 | |
| Igm Biosciences (IGMS) | 4.9 | $177M | 3.1M | 56.15 | |
| Argenx Se (ARGX) | 4.0 | $143M | 1.1M | 131.73 | |
| Momenta Pharmaceuticals | 3.9 | $141M | 5.2M | 27.20 | |
| Epizyme | 3.8 | $136M | 8.8M | 15.51 | |
| Principia Biopharma | 3.8 | $134M | 2.3M | 59.38 | |
| Allakos | 3.7 | $132M | 3.0M | 44.49 | |
| Uniqure Nv (QURE) | 3.7 | $132M | 2.8M | 47.45 | |
| Aprea Therapeutics | 2.2 | $79M | 2.3M | 34.76 | |
| Regenxbio Inc equity us cm (RGNX) | 2.1 | $76M | 2.3M | 32.38 | |
| Seattle Genetics | 2.1 | $76M | 656k | 115.38 | |
| Nevro (NVRO) | 2.0 | $71M | 706k | 99.98 | |
| Merck & Co (MRK) | 1.7 | $61M | 789k | 76.94 | |
| Beam Therapeutics (BEAM) | 1.7 | $61M | 3.4M | 18.00 | |
| UnitedHealth (UNH) | 1.7 | $60M | 241k | 249.38 | |
| ImmunoGen | 1.6 | $57M | 17M | 3.41 | |
| Tandem Diabetes Care (TNDM) | 1.6 | $57M | 881k | 64.35 | |
| 1life Healthcare | 1.6 | $57M | 3.1M | 18.15 | |
| Novartis (NVS) | 1.5 | $54M | 654k | 82.45 | |
| Cigna Corp (CI) | 1.5 | $53M | 301k | 177.18 | |
| Stoke Therapeutics (STOK) | 1.4 | $50M | 2.2M | 22.90 | |
| Centene Corporation (CNC) | 1.4 | $49M | 824k | 59.41 | |
| Tricida | 1.3 | $47M | 2.1M | 22.00 | |
| Neoleukin Therapeutics | 1.3 | $46M | 4.0M | 11.38 | |
| Krystal Biotech (KRYS) | 1.3 | $46M | 1.1M | 43.24 | |
| Atara Biotherapeutics | 1.3 | $45M | 5.3M | 8.51 | |
| Axonics Modulation Technolog (AXNX) | 1.1 | $38M | 1.5M | 25.41 | |
| Pra Health Sciences | 1.0 | $37M | 443k | 83.04 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $35M | 2.9M | 12.11 | |
| Dex (DXCM) | 1.0 | $35M | 129k | 269.27 | |
| Eidos Therapeutics | 0.9 | $34M | 690k | 48.99 | |
| Genmab A/s -sp (GMAB) | 0.9 | $33M | 1.5M | 21.19 | |
| Amedisys (AMED) | 0.9 | $33M | 178k | 183.54 | |
| Cryoport Inc Com Par $0 001 (CYRX) | 0.9 | $31M | 1.8M | 17.07 | |
| Zymeworks | 0.9 | $31M | 869k | 35.47 | |
| Replimune Group (REPL) | 0.8 | $30M | 3.0M | 9.97 | |
| Wave Life Sciences (WVE) | 0.8 | $27M | 2.9M | 9.37 | |
| Catalent | 0.7 | $26M | 506k | 51.95 | |
| Ppd | 0.6 | $23M | 1.3M | 17.81 | |
| Ardelyx (ARDX) | 0.6 | $22M | 3.9M | 5.68 | |
| Odonate Therapeutics Ord | 0.5 | $20M | 708k | 27.61 | |
| Atreca Inc Cl A (BCEL) | 0.5 | $19M | 1.1M | 16.55 | |
| Shockwave Med | 0.5 | $19M | 558k | 33.18 | |
| Twist Bioscience Corp (TWST) | 0.5 | $18M | 590k | 30.58 | |
| Gritstone Oncology Ord (GRTSQ) | 0.5 | $18M | 3.1M | 5.82 | |
| Hookipa Pharma Inc equity | 0.4 | $15M | 1.9M | 8.25 | |
| Tcr2 Therapeutics Inc cs | 0.4 | $14M | 1.8M | 7.74 | |
| Akero Therapeutics (AKRO) | 0.3 | $12M | 570k | 21.20 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $12M | 414k | 27.78 | |
| Cabaletta Bio (CABA) | 0.3 | $10M | 1.4M | 7.30 | |
| Biontech Se (BNTX) | 0.3 | $9.9M | 170k | 58.40 | |
| Stereotaxis (STXS) | 0.3 | $9.4M | 3.1M | 3.02 | |
| Rts/bristol-myers Squibb Compa | 0.3 | $9.1M | 2.4M | 3.80 | |
| Itamar Med | 0.2 | $7.4M | 625k | 11.78 | |
| Revolution Medicines (RVMD) | 0.2 | $6.6M | 303k | 21.91 | |
| Xeris Pharmaceuticals | 0.2 | $5.8M | 3.0M | 1.95 | |
| Cymabay Therapeutics | 0.1 | $4.1M | 2.8M | 1.48 | |
| Profound Med Corp (PROF) | 0.1 | $3.9M | 400k | 9.74 | |
| Gossamer Bio (GOSS) | 0.1 | $2.6M | 260k | 10.15 | |
| Syros Pharmaceuticals | 0.0 | $1.3M | 212k | 5.93 | |
| Clovis Oncology | 0.0 | $633k | 100k | 6.36 | |
| Glycomimetics | 0.0 | $578k | 254k | 2.28 | |
| Vapotherm | 0.0 | $471k | 25k | 18.84 | |
| Ovid Therapeutics (OVID) | 0.0 | $363k | 122k | 2.98 | |
| Endologix | 0.0 | $54k | 79k | 0.69 | |
| Castlight Health | 0.0 | $7.0k | 10k | 0.68 |
